On 2 separate days all participants were admitted to the Hospital Research Unit (HRU) of Yale University School of Medicine at 8.00 a.m. following a 10 -12 h overnight fast for either a 2 hour OGTT (1.75 g/Kg body weight, up to 75 g) and lipid profile or a Hyperinsulinemic euglycemic clamp.
Following a 10hr overnight fast, at 7 am, two intravenous catheters, one for blood sampling and one for infusion of glucose, insulin, and tracers, were inserted in the antecubital vein of each arm after local lidocaine infiltration. The sampling arm was kept in a heated box for arterialization of blood. Wholebody insulin sensitivity was measured by 2 step euglycemic clamp, by infusing insulin as a primed continuous infusion at 4 mU·m -2 ·min -1 ·and 80 mU·m -2 ·min -1 . Each step lasted 2h. A primed continuous infusion of 6,6-deuterium glucose and of 2 H 5 -glycerol were used to quantify insulin's effects on glucose and glycerol turnover. To maintain the plasma enrichment of 2 D-Glucose constant at baseline value throughout the clamp, we used the Hot GINF method (12,6). Arterialized blood samples were collected every 10 min during the last 30 min of the baseline period and during each step of the clamp for measurement of glucose and glycerol enrichments, hormones, and substrates. Glucose disposal was calculated as the mean rate of glucose infusion measured during the last 30 min of the clamp (steady state) and is expressed as milligrams per minute per kilogram of lean body mass (LBM) (mg·min -1 ·kg -1 ). 
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